Varaico: Literature-Extracted Genetic Variants

Gene:PMM2
Variant:p.Q33P
Back to variants list

PMM2

NM_000303.3:p.Q33P

Associated Papers

Dynamicasome-a molecular dynamics-guided and AI-driven pathogenicity prediction catalogue for all genetic mutations.

Islam NN et al.

Communications Biology, 2025

40624350 (PubMed )
Supplement: 42003_2025_8334_MOESM3_ESM.zip › PMM2-mutation-prediction-with-AI › Latest_AllModel_WithOutSide_Program_May10th_2024.xlsx › Sheet1

Goal attainment in PMM2-CDG: A new approach measuring meaningful clinical outcomes.

Verberkmoes S et al.

Molecular Genetics and Metabolism, 2025

Neurodevelopmental profiles of 14 individuals with phosphomannomutase deficiency (PMM2-CDG).

Weixel T et al.

Journal of Inherited Metabolic Disease, 2025

A complement C4-derived glycopeptide is a biomarker for PMM2-CDG.

Garapati K et al.

Jci Insight, 2024

Genotype/Phenotype Relationship: Lessons From 137 Patients With PMM2-CDG.

Pajusalu S et al.

Human Mutation, 2024

Tracer metabolomics reveals the role of aldose reductase in glycosylation.

Radenkovic S et al.

Cell Reports. Medicine, 2023

37257447 (PubMed )
Supplement: mmc1.pdf

Coagulation abnormalities in a prospective cohort of 50 patients with PMM2-congenital disorder of glycosylation.

De Graef D et al.

Molecular Genetics and Metabolism, 2023

Elevated oxysterol and N-palmitoyl-O-phosphocholineserine levels in congenital disorders of glycosylation.

Dang Do AN et al.

Journal of Inherited Metabolic Disease, 2023

Insight on molecular pathogenesis and pharmacochaperoning potential in phosphomannomutase 2 deficiency, provided by novel human phosphomannomutase 2 structures.

Briso-Montiano A et al.

Journal of Inherited Metabolic Disease, 2022

Genotype-Phenotype Correlations in PMM2-CDG.

Vaes L et al.

Genes, 2021

D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trial.

Witters P et al.

Orphanet Journal of Rare Diseases, 2021

Liver manifestations in a cohort of 39 patients with congenital disorders of glycosylation: pin-pointing the characteristics of liver injury and proposing recommendations for follow-up.

Starosta RT et al.

Orphanet Journal of Rare Diseases, 2021

New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach.

Francisco R et al.

Journal of Clinical Medicine, 2020

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."